Sotera Health

SHC

Market cap $4.64B

CLEVELAND, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 20,000,000 shares of its common stock, par value $0.01 per share. All 20,000,000 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company will pay the expenses of the Offering pursuant to its obligations under its Amended and Restated Registration Rights Agreement.

Sotera Health Company (SHC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SHC's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Sotera Health Company (NASDAQ:SHC ) Q2 2025 Earnings Conference Call August 8, 2025 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Jonathan M. Lyons - Senior VP & CFO Michael B.

Image source: The Motley Fool.

Sotera Health (SHC) Q2 Revenue Up 6%

CLEVELAND, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three- and six- months ended June 30, 2025.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Sotera Health (SHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

CLEVELAND, July 28, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the second-quarter ended June 30, 2025 before the market opens on Friday, August 8, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company's financial results and operating highlights.

The Qatar infection control market is driven by automated and AI-powered sterilization systems. Rising hospital admissions, awareness of healthcare-associated infections, and advanced disinfection technologies further propel growth. The Qatar infection control market is driven by automated and AI-powered sterilization systems. Rising hospital admissions, awareness of healthcare-associated infections, and advanced disinfection technologies further propel growth.